Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gitsch

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Archives of Gynecology and Obstetrics|January 1, 1992
Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasiaG Gitsch, C Kainz, M Studnicka, et al.
Annals of Surgical Oncology|March 5, 2009
Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer populationM Klar, M Foeldi, S Markert, et al.
Anticancer Research|July 1, 1996
Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinomaC Tempfer, G Gitsch, E Hanzal, et al.
Obstetrics and Gynecology|August 29, 1998
Vascular endothelial growth factor serum concentrations in ovarian cancerC Tempfer, A Obermair, L Hefler, et al.
Maturitas|November 1, 1994
Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot studyJ B Schmidt, M Binder, W Macheiner, et al.
Archives of Gynecology and Obstetrics|January 1, 1993
When applied to facial skin, does estrogen ointment have systemic effects?C Kainz, G Gitsch, J Stani, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2010
Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practiceK Hancke, M Foeldi, H P Zahradnik, et al.
Anticancer Research|September 3, 1999
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancerP L Moser, L Hefler, C Tempfer, et al.
Anticancer Research|November 1, 1992
Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filamentsG Gitsch, C Kainz, P Kohlberger, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Prognostic value of CD44 splice variants in human stage III cervical cancerC Kainz, P Kohlberger, C Tempfer, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Archives of Gynecology and Obstetrics|January 1, 1992
Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasiaG Gitsch, C Kainz, M Studnicka, et al.
Annals of Surgical Oncology|March 5, 2009
Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer populationM Klar, M Foeldi, S Markert, et al.
Anticancer Research|July 1, 1996
Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinomaC Tempfer, G Gitsch, E Hanzal, et al.
Obstetrics and Gynecology|August 29, 1998
Vascular endothelial growth factor serum concentrations in ovarian cancerC Tempfer, A Obermair, L Hefler, et al.
Maturitas|November 1, 1994
Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot studyJ B Schmidt, M Binder, W Macheiner, et al.
Archives of Gynecology and Obstetrics|January 1, 1993
When applied to facial skin, does estrogen ointment have systemic effects?C Kainz, G Gitsch, J Stani, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2010
Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practiceK Hancke, M Foeldi, H P Zahradnik, et al.
Anticancer Research|September 3, 1999
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancerP L Moser, L Hefler, C Tempfer, et al.
Anticancer Research|November 1, 1992
Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filamentsG Gitsch, C Kainz, P Kohlberger, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Prognostic value of CD44 splice variants in human stage III cervical cancerC Kainz, P Kohlberger, C Tempfer, et al.
Pageof 13